Exchange: NASDAQ·Updated 09:45 AM EDT
News
all
press releases
Lifeward (LFWD) Reports Q2 Loss, Misses Revenue Estimates
Lifeward (LFWD) delivered earnings and revenue surprises of +2.01% and -10.74%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
More News
Ovid Therapeutics (OVID) Reports Q2 Loss, Beats Revenue Estimates
Ovid Therapeutics (OVID) delivered earnings and revenue surprises of +20.00% and +388.67%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Sonida Senior Living (SNDA) Reports Q2 Loss, Tops Revenue Estimates
Sonida Senior Living (SNDA) delivered earnings and revenue surprises of -477.78% and +0.69%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Natera (NTRA) Reports Q2 Loss, Beats Revenue Estimates
Natera (NTRA) delivered earnings and revenue surprises of 0.00% and +14.23%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Oramed Releases Letter to Shareholders, Highlighting Russell 2000/3000 Index Inclusion, Scilex Loan Repayment, Strategic Portfolio Appreciation, and a Strengthened Balance Sheet
Oramed Releases Letter to Shareholders, Highlighting Russell 2000/3000 Index Inclusion, Scilex Loan Repayment, Strategic Portfolio Appreciation, and a Strengthened Balance Sheet Oramed Releases Letter to Shareholders, Highlighting Russell 2000/3000 Index Inclusion, Scilex Loan Repayment, Strategic...
PR Newswire
Lifeward (LFWD) Reports Q1 Loss, Lags Revenue Estimates
Lifeward (LFWD) delivered earnings and revenue surprises of -1,870.59% and -35.69%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Keros Therapeutics, Inc. (KROS) Reports Q1 Loss, Misses Revenue Estimates
Keros Therapeutics (KROS) delivered earnings and revenue surprises of -31.52% and -93.01%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Shoulder Innovations, Inc. (SI) Reports Q1 Loss, Tops Revenue Estimates
Shoulder Innovations, Inc. (SI) delivered earnings and revenue surprises of +6.82% and +16.43%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
CryoPort, Inc. (CYRX) Reports Q1 Loss, Tops Revenue Estimates
CryoPort (CYRX) delivered earnings and revenue surprises of -15.00% and +6.41%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
HCA Healthcare (HCA) Q1 Earnings and Revenues Miss Estimates
HCA (HCA) delivered earnings and revenue surprises of -0.27% and -0.07%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks

Advertisement|Remove ads.